Letter to the Editor: Central nervous system relapse rate and dose intensification in poor risk metastatic germ cell tumours-A comment on: 'Patterns of relapse in poor prognosis germ cell tumours in the GETUG-13 trial: Implications for the assessment of brain metastases.' by Loriot and colleagues
作者:
发布时间
2018-12-20
- 浏览0
European journal of cancer
102-103页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文